These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 18298489)

  • 1. Independent measures of insulin secretion and insulin sensitivity during the same test: the glucagon-insulin tolerance test.
    Dorkhan M; Tripathy D; Malm G; Asgharian H; Tuomi T; Groop L
    J Intern Med; 2008 Jul; 264(1):62-71. PubMed ID: 18298489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
    Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
    Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of obtaining independent measures of insulin secretion and insulin sensitivity during the same test: results with the Botnia clamp.
    Tripathy D; Wessman Y; Gullström M; Tuomi T; Groop L
    Diabetes Care; 2003 May; 26(5):1395-401. PubMed ID: 12716795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.
    Fritsche A; Stefan N; Hardt E; Schützenauer S; Häring H; Stumvoll M
    Eur J Clin Invest; 2000 May; 30(5):411-8. PubMed ID: 10809901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
    Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
    Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance.
    Berrish TS; Hetherington CS; Alberti KG; Walker M
    Diabetologia; 1995 Jun; 38(6):699-704. PubMed ID: 7672492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.
    Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
    Scand J Clin Lab Invest; 2007; 67(3):327-36. PubMed ID: 17454847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between Serum 25-Hydroxyvitamin D, Insulin Sensitivity, Insulin Secretion, and β-Cell Function According to Glucose Tolerance Status.
    Morisset AS; Tardio V; Weisnagel J; Lemieux S; Bergeron J; Gagnon C
    Metab Syndr Relat Disord; 2015 Jun; 13(5):208-13. PubMed ID: 25781493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp.
    Akinmokun A; Selby PL; Ramaiya K; Alberti KG
    Diabet Med; 1992 Jun; 9(5):432-7. PubMed ID: 1611830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting serum total bile acid levels are associated with insulin sensitivity, islet β-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes.
    Wang XH; Xu F; Cheng M; Wang X; Zhang DM; Zhao LH; Cai HL; Huang HY; Chen T; Zhang XL; Wang XQ; Cheng XB; Su JB; Lu Y
    Endocr J; 2020 Nov; 67(11):1107-1117. PubMed ID: 32684527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion.
    Cretti A; Lehtovirta M; Bonora E; Brunato B; Zenti MG; Tosi F; Caputo M; Caruso B; Groop LC; Muggeo M; Bonadonna RC
    Eur J Clin Invest; 2001 May; 31(5):405-16. PubMed ID: 11380592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of danazol-induced chronic hyperglucagonaemia on glucose tolerance and turnover.
    Kotzmann H; Linkesch M; Ludvik B; Clodi M; Luger A; Schernthaner G; Prager R; Klauser R
    Eur J Clin Invest; 1995 Dec; 25(12):942-7. PubMed ID: 8719935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies.
    Bonora E; Moghetti P; Zancanaro C; Cigolini M; Querena M; Cacciatori V; Corgnati A; Muggeo M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):374-8. PubMed ID: 2645308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations.
    Nyholm B; Walker M; Gravholt CH; Shearing PA; Sturis J; Alberti KG; Holst JJ; Schmitz O
    Diabetologia; 1999 Nov; 42(11):1314-23. PubMed ID: 10550415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion.
    Abdul-Ghani M; DeFronzo RA
    J Clin Endocrinol Metab; 2007 May; 92(5):1778-84. PubMed ID: 17327375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.
    D'Alessio DA; Kahn SE; Leusner CR; Ensinck JW
    J Clin Invest; 1994 May; 93(5):2263-6. PubMed ID: 8182159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of norepinephrine on insulin secretion and glucose effectiveness in non-insulin-dependent diabetes.
    Walters JM; Ward GM; Barton J; Arackal R; Boston RC; Best JD; Alford FP
    Metabolism; 1997 Dec; 46(12):1448-53. PubMed ID: 9439541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
    Fujita Y; Kozawa J; Iwahashi H; Yoneda S; Uno S; Yoshikawa A; Okita K; Eguchi H; Nagano H; Imagawa A; Shimomura I
    Endocr J; 2015; 62(4):329-37. PubMed ID: 25740613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.